Placental particles in placenta previa and accreta
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study looks at tiny particles released by the placenta in pregnant women with placenta previa or accreta spectrum. It aims to understand how these particles might help diagnose or manage these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and at least 18 years old.
- You have been diagnosed with placenta previa or placenta accreta spectrum, OR you are a healthy pregnant woman.
- You are carrying a single baby (not twins or more).
- You do not have a chronic infection or cancer.
- You are able to give written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying a new approach to prevent and treat a pregnancy complication called placenta accreta spectrum (where the placenta grows too deeply into the uterus). It aims to help pregnant women diagnosed with this condition improve their outcomes.
This study compares three different surgical methods to safely treat placenta accreta spectrum, a condition where the placenta grows too deeply into the uterus. The goal is to find which approach works best with fewer complications.
This study looks at a possible link between certain proteins in the blood (VEGF family) and a pregnancy condition called placenta previa, using genetic information from existing studies. It is not a treatment trial, but a research study that analyzes data to understand causes.
This study follows pregnant women who may have placenta accreta—a condition where the placenta grows too deeply into the uterus. Researchers will measure the length of the cervix and how deeply the placenta is attached using ultrasound to help guide care during pregnancy.
This trial studies what happens after a planned C-section when placenta accreta spectrum is diagnosed by ultrasound and the uterus is kept. It may help doctors understand the safest way to manage this condition and what outcomes to expect.
This trial looks at how to diagnose and what happens to pregnant women with a condition where the placenta grows too deeply into the uterus (placental accreta). It may help doctors better understand the condition and improve care.
Hear when a new Placenta Previa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.